Dette indbefatter øget risiko for skeletal manifestation, eksacerbation af cytopeni, hæmoragi og øget behov for transfusion.
This includes an increased risk of skeletal manifestations, exacerbation of cytopenia, haemorrhage, and an increased need for transfusion.